These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 32556712)

  • 1. Late complications and quality of life assessment for survivors receiving allogeneic hematopoietic stem cell transplantation.
    Cheon J; Lee YJ; Jo JC; Kweon K; Koh S; Min YJ; Park SH; Lee SH; Kim HJ; Choi Y
    Support Care Cancer; 2021 Feb; 29(2):975-986. PubMed ID: 32556712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of lung transplantation after allogeneic hematopoietic stem cell transplantation.
    Cheng GS; Edelman JD; Madtes DK; Martin PJ; Flowers ME
    Biol Blood Marrow Transplant; 2014 Aug; 20(8):1169-75. PubMed ID: 24727334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of Life following Allogeneic Stem Cell Transplantation for Patients Age >60 Years with Acute Myelogenous Leukemia.
    Wright R; Oremek M; Davies D; Kewley C; Singh A; Taitt N; Kempshall E; Wilson K; Ingram W
    Biol Blood Marrow Transplant; 2020 Aug; 26(8):1527-1533. PubMed ID: 32422252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health status, late effects and long-term survivorship of allogeneic bone marrow transplantation: a retrospective study.
    Gifford G; Sim J; Horne A; Ma D
    Intern Med J; 2014 Feb; 44(2):139-47. PubMed ID: 24320824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The quality of life following allogeneic hematopoietic stem cell transplantation - a multicenter retrospective study.
    Valkova V; Jircikova J; Trnkova M; Steinerova K; Keslova P; Lanska M; Koristek Z; Raida L; Krejci M; Kruntoradova K; Dolezal T; Benesova K; Cetkovsky P; Trneny M
    Neoplasma; 2016; 63(5):743-51. PubMed ID: 27468878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surviving the cure: long term followup of hematopoietic cell transplant recipients.
    Majhail NS; Rizzo JD
    Bone Marrow Transplant; 2013 Sep; 48(9):1145-51. PubMed ID: 23292238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of post traumatic growth in allogeneic hematopoietic stem cell transplantation survivors: a cross-sectional survey.
    McErlean G; Tapp C; Brice L; Gilroy N; Kabir M; Greenwood M; Larsen SR; Moore J; Gottlieb D; Hertzberg M; Brown L; Hogg M; Huang G; Ward C; Kerridge I
    BMC Psychol; 2023 Aug; 11(1):235. PubMed ID: 37587508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does anti-thymocyte globulin have a place in busulfan/fludarabine conditioning for matched related donor hematopoietic stem cell transplantation?
    Ji YS; Lee MS; Min CW; Park SK; Kim SH; Yun J; Kim HJ; Kim KH; Kim CK; Lee KT; Won JH; Hong DS
    Korean J Intern Med; 2016 Jul; 31(4):750-61. PubMed ID: 27017944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Age >69 Years with Acute Myelogenous Leukemia: On Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
    Ringdén O; Boumendil A; Labopin M; Canaani J; Beelen D; Ehninger G; Niederwieser D; Finke J; Stelljes M; Gerbitz A; Ganser A; Kröger N; Kantz L; Brecht A; Savani B; Sadeghi B; Mohty M; Nagler A
    Biol Blood Marrow Transplant; 2019 Oct; 25(10):1975-1983. PubMed ID: 31181255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spermatogenesis in long-term survivors after allogeneic hematopoietic stem cell transplantation is associated with age, time interval since transplantation, and apparently absence of chronic GvHD.
    Rovó A; Tichelli A; Passweg JR; Heim D; Meyer-Monard S; Holzgreve W; Gratwohl A; De Geyter C
    Blood; 2006 Aug; 108(3):1100-5. PubMed ID: 16543466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haematopoietic stem cell transplantation survivorship and quality of life: is it a small world after all?
    Brice L; Gilroy N; Dyer G; Kabir M; Greenwood M; Larsen S; Moore J; Kwan J; Hertzberg M; Brown L; Hogg M; Huang G; Tan J; Ward C; Gottlieb D; Kerridge I
    Support Care Cancer; 2017 Feb; 25(2):421-427. PubMed ID: 27699502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late Complications and Quality of Life after Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation.
    Clavert A; Peric Z; Brissot E; Malard F; Guillaume T; Delaunay J; Dubruille V; Le Gouill S; Mahe B; Gastinne T; Blin N; Harousseau JL; Moreau P; Milpied N; Mohty M; Chevallier P
    Biol Blood Marrow Transplant; 2017 Jan; 23(1):140-146. PubMed ID: 27751934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome and late effects among acute myeloid leukemia survivors: a nationwide population-based study.
    Chang KH; Hwang WL; Muo CH; Hsu CY; Teng CJ
    Support Care Cancer; 2016 Dec; 24(12):4993-5000. PubMed ID: 27502072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic characteristics of secondary squamous cell carcinoma of head and neck in survivors of allogeneic hematopoietic stem cell transplantation for hematologic malignancies.
    Chaulagain CP; Sprague KA; Pilichowska M; Cowan J; Klein AK; Kaul E; Miller KB
    Bone Marrow Transplant; 2019 Apr; 54(4):560-566. PubMed ID: 30127467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Who Is a Better Donor for Recipients of Allogeneic Hematopoietic Cell Transplantation: A Young HLA-Mismatched Haploidentical Relative or an Older Fully HLA-Matched Sibling or Unrelated Donor?
    Karam E; Laporte J; Solomon SR; Morris LE; Zhang X; Holland HK; Bashey A; Solh MM
    Biol Blood Marrow Transplant; 2019 Oct; 25(10):2054-2060. PubMed ID: 31173900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloablative allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adults: significant roles of total body irradiation and chronic graft-versus-host disease.
    Yanada M; Naoe T; Iida H; Sakamaki H; Sakura T; Kanamori H; Kodera Y; Okamoto S; Kanda Y; Sao H; Asai O; Nakai K; Maruta A; Kishi K; Furukawa T; Atsuta Y; Yamamoto K; Tanaka J; Takahashi S
    Bone Marrow Transplant; 2005 Nov; 36(10):867-72. PubMed ID: 16113659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic HSCT for autoimmune diseases: conventional conditioning regimens.
    Nash RA
    Bone Marrow Transplant; 2003 Aug; 32 Suppl 1():S77-80. PubMed ID: 12931249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A survey of infectious diseases and vaccination uptake in long-term hematopoietic stem cell transplant survivors in Australia.
    Dyer G; Gilroy N; Brice L; Kabir M; Gottlieb D; Huang G; Hogg M; Brown L; Greenwood M; Larsen SR; Moore J; Hertzberg M; Tan J; Ward C; Kerridge I
    Transpl Infect Dis; 2019 Apr; 21(2):e13043. PubMed ID: 30585673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of cardiorespiratory fitness in very long-term survivors of allogeneic hematopoietic stem cell transplantation: a national cohort study.
    Myrdal OH; Diep PP; Ruud E; Brinch L; Massey RJ; Edvardsen E; Kongerud J; Lund MB; Sikkeland LI
    Support Care Cancer; 2021 Apr; 29(4):1959-1967. PubMed ID: 32827056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early and late complications following hematopoietic stem cell transplantation in pediatric patients - A retrospective analysis over 11 years.
    Hierlmeier S; Eyrich M; Wölfl M; Schlegel PG; Wiegering V
    PLoS One; 2018; 13(10):e0204914. PubMed ID: 30325953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.